Literature DB >> 11285059

Serum levels of neutrophil activation cytokines in Kawasaki disease.

H Suzuki1, E Noda, M Miyawaki, T Takeuchi, S Uemura, M Koike.   

Abstract

BACKGROUND: The aim of the present study was to investigate whether neutrophils are early effector cells for vascular endothelial damage in the acute phase of Kawasaki disease (KD) by examining serial changes in neutrophil counts and serum levels of neutrophil activation cytokines, such as granulocyte colony stimulating factor (G-CSF) and interleukin (IL)-8.
METHODS: From October 1994 to June 1998, a total of 52 patients with KD were included in the study. Thirty-three patients had some infectious diseases, while 20 healthy children served as control subjects. Serial changes in neutrophils were counted by the optimal Wright-Giemsa staining method and serum levels of IL-8 and G-CSF in patients with KD were measured by an enzyme-linked immunosorbent assay system.
RESULTS: Serum G-CSF levels both before and after intravenous immunoglobulin therapy (IVIG; P<0.05) and neutrophil counts after IVIG (P<0.005) were higher in KD patients with coronary arterial lesions (CAL) than those without CAL. However, serum IL-8 levels before and after IVIG showed no significant differences in these two groups.
CONCLUSIONS: These data suggest that neutrophils may be important as early effector cells for vascular endothelial damage and that G-CSF may play a more important role than IL-8 in KD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11285059     DOI: 10.1046/j.1442-200x.2001.01362.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  12 in total

1.  Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.

Authors:  K Ikeda; K Yamaguchi; T Tanaka; Y Mizuno; A Hijikata; O Ohara; H Takada; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

2.  Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.

Authors:  R Venkatraman; S Singh; R W Minz
Journal:  Rheumatol Int       Date:  2005-11-25       Impact factor: 2.631

3.  Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C.

Authors:  Yanfang P Zhu; Isaac Shamie; Jamie C Lee; Cameron J Nowell; Weiqi Peng; Shiela Angulo; Linh Nn Le; Yushan Liu; Huilai Miao; Hainan Xiong; Cathleen J Pena; Elizabeth Moreno; Eric Griffis; Stephanie G Labou; Alessandra Franco; Lori Broderick; Hal M Hoffman; Chisato Shimizu; Nathan E Lewis; John T Kanegaye; Adriana H Tremoulet; Jane C Burns; Ben A Croker
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

4.  Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness.

Authors:  Hyo Seok Chung; Hyo Young Kim; Hee Sun Kim; Hee Jung Lee; Ji Hyun Yuh; Eun Sil Lee; Kwang Hae Choi; Young Hwan Lee
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

5.  Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.

Authors:  T Kobayashi; H Kimura; Y Okada; Y Inoue; T Kobayashi; M Shinohara; A Morikawa
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

6.  Parameters to guide retreatment after initial intravenous immunoglobulin therapy in kawasaki disease.

Authors:  Hyun Kwon Kim; Jungeun Oh; Young Mi Hong; Sejung Sohn
Journal:  Korean Circ J       Date:  2011-07-30       Impact factor: 3.243

7.  Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study.

Authors:  Eun Chun Han; Sung Bin Cho; Keun Jae Ahn; Sang Ho Oh; Jihyun Kim; Dong Soo Kim; Kwang Hoon Lee; Dongsik Bang
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

8.  GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease.

Authors:  Angus T Stock; Jacinta A Hansen; Matthew A Sleeman; Brent S McKenzie; Ian P Wicks
Journal:  J Exp Med       Date:  2016-09-05       Impact factor: 14.307

9.  MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki Disease.

Authors:  Hideyuki Nakaoka; Keiichi Hirono; Seiji Yamamoto; Ichiro Takasaki; Kei Takahashi; Koshi Kinoshita; Asami Takasaki; Naonori Nishida; Mako Okabe; Wang Ce; Nariaki Miyao; Kazuyoshi Saito; Keijiro Ibuki; Sayaka Ozawa; Yuichi Adachi; Fukiko Ichida
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

Review 10.  Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.

Authors:  Caroline Galeotti; Jagedeesh Bayry; Isabelle Kone-Paut; Srinivas V Kaveri
Journal:  Autoimmun Rev       Date:  2010-01-13       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.